Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$125.47M
↑ 584% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-25.90M
Historical baseline
PeriodValueYoY Change
2025$125.47M+418.6%
2024$24.19M+218.1%
2023$-20.49M+63.1%
2022$-55.55M-344.5%
2021$-12.50M+56.9%
2020$-28.97M+58.1%
2019$-69.09M+4.9%
2018$-72.68M+8.7%
2017$-79.62M-14.2%
2016$-69.74M-